Skip to main content
Clinical Trials/NL-OMON22716
NL-OMON22716
Recruiting
Not Applicable

Personalized approach using wearable technology for early detection of Atrial Fibrillation in first line high-risk patients: study protocol for a cluster randomized controlled trial.

Amsterdam University Medical Center, location AMC0 sites930 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial fibrillation
Sponsor
Amsterdam University Medical Center, location AMC
Enrollment
930
Status
Recruiting
Last Updated
last year